1. Analyst View
2. Research Methodology
3. Introduction to Genetic Testing
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 Genetic Testing Laboratories - Unmet Need Analysis
4.3 DTC Genetic Testing
5. Disease-Wise Analysis
5.1 Alzheimer's Disease
5.2 Cystic Fibrosis
5.3 Cancer
6. Country-Level Analysis
6.1 US
6.1.1 Market Overview
6.1.2 Recent Developments
6.2 Europe
6.2.1 Market Overview
6.2.2 Recent Developments
6.3 Asia
6.3.1 Market Overview
6.3.2 Recent Developments
7. Emerging Sectors
7.1 Next-Generation Sequencing
7.2 Non-Invasive Prenatal diagnostics (NIPD)
7.3 Whole Genome Sequencing (WGS) for Cancer
7.4 Personalized medicine
8. Competitive Assessment
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Product Offering
8.1.3 Key Financials
8.1.4 Recent Developments
8.1.5 Strengths & Weaknesses
8.2 Roche Diagnostics
8.2.1 Company Overview
8.2.2 Product Offering
8.2.3 Key Financials
8.2.4 Recent Developments
8.2.5 Strengths & Weaknesses
8.3 Myriad Genetics
8.3.1 Company Overview
8.3.2 Product Offering
8.3.3 Key Financials
8.3.4 Recent Developments
8.3.5 Strengths & Weaknesses
8.4 Life Technologies Corporation
8.4.1 Company Overview
8.4.2 Product Offering
8.4.3 Key Financials
8.4.4 Recent Developments
8.4.5 Strengths & Weaknesses
8.5 Genomic Health
8.5.1 Company Overview
8.5.2 Product Offering
8.5.3 Key Financials
8.5.4 Recent Developments
8.5.5 Strengths & Weaknesses
8.6 Sequenom
8.6.1 Company Overview
8.6.2 Product Offering
8.6.3 Key Financials
8.6.4 Recent Developments
8.6.5 Strengths & Weaknesses
8.7 Transgenomic
8.7.1 Company Overview
8.7.2 Product Offering
8.7.3 Key Financials
8.7.4 Recent Developments
8.7.5 Strengths & Weaknesses
8.8 Dako (Agilent Technologies)
8.8.1 Company Overview
8.8.2 Product Offering
8.8.3 Key Financials
8.8.4 Recent Development
8.8.5 Strengths & Weaknesses
8.9 Gen-Probe (Hologic)
8.9.1 Company Overview
8.9.2 Product Offering
8.9.3 Key Financials
8.9.4 Key Activities
8.9.5 Strengths & Weaknesses
8.10 Quest Diagnostics
8.10.1 Company Overview
8.10.2 Products Offerings
8.10.3 Key Financials
8.10.4 Recent Developments
8.10.5 Strengths and Weaknesses
8.11 Genoptix (Novartis)
8.11.1 Company Overview
8.11.2 Product Offerings
8.11.3 Key Financials
8.11.4 Recent Developments
8.11.5 Strengths and Weaknesses
8.12 Clarient (GE Healthcare)
8.12.1 Company Overview
8.12.2 Product Offerings
8.12.3 Key Financials
8.12.4 Recent Developments
8.12.5 Strengths and Weaknesses